Cite
MLA Citation
XS Xu et al.. “Clinical Implications of Complex Pharmacokinetics for Daratumumab Dose Regimen in Patients With Relapsed/Refractory Multiple Myeloma.” Clinical pharmacology & therapeutics, vol. 101, no. 6, 2017, pp. 721–724. http://access.bl.uk/ark:/81055/vdc_100046379668.0x00005a